Hepatitis C Virus
XTL Biopharmaceuticals Announces Financial Results for the Year Ended December 31, 2006
Published in Hepatitis Weekly, March 26th, 2007
At December 31, 2006, the Company had cash, cash equivalents and short-term bank deposits of $25.2 million, compared to cash and cash equivalents of $13.4 million at December 31, 2005. The year-over-year increase of $11.8 million is attributable primarily to the Company's completion in May of a private placement of ordinary shares yielding $24.4...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2007-03-26)
More Articles from Hepatitis Weekly
- Financials
MIGENIX Reports Third Quarter Fiscal Year 2007 Financial Results - Hepatitis B Virus
Cangene's HepaGam B Added to Novation's Product Listing Allowing the Product to Reach Nearly 2,500 Healthcare Organizations - Hepatitis C Virus
Roche Driving PROGRESS in Treatment of Hepatitis C Patients with New PEGASYS Trial - Patents
Metabasis Therapeutics Reports on 2006 Financial Results and Business Accomplishments and Provides Guidance for 2007 - Hepatitis A Virus Epidemiology
Researchers from Norwegian Institute of Public Health, Division of Infectious Disease detail findings in hepatitis A virus epidemiology - Hepatitis B Virus
Lok Nayak Hospital, Maulana Azad Medical College reports research in hepatitis B virus - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
